about
Clinical and morphological determinants of focal neurological deficits in patients with unruptured brain arteriovenous malformationEpidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection.Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data.Vascular risk factors and morphometric data in cervical artery dissection: a case-control study.The epidemiology of brain arteriovenous malformations.Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors.The ARUBA trial: current status, future hopesIschemic stroke therapy.Predictors of hemorrhage in patients with untreated brain arteriovenous malformation.Subarachnoid hemorrhage induces an early and reversible cardiac injury associated with catecholamine release: one-week follow-up studyFamilial occurrence and heritable connective tissue disorders in cervical artery dissectionSpontaneous intracerebral haemorrhage.Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2.Concurrent arterial aneurysms in brain arteriovenous malformations with haemorrhagic presentationLow Ambient Temperature and Intracerebral Hemorrhage: The INTERACT2 Study.Diagnosis and treatment of dural carotid-cavernous fistulas: a consecutive series of 27 patients.Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy.European research priorities for intracerebral haemorrhage.Early Blood Pressure Lowering Does Not Reduce Growth of Intraventricular Hemorrhage following Acute Intracerebral Hemorrhage: Results of the INTERACT Studies.Intracerebral hemorrhage location and outcome among INTERACT2 participants.Stroke unit management and revascularisation in acute ischemic stroke.Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results.Significance of Hematoma Shape and Density in Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Intracerebral Hemorrhage Trial Study.Significance of Cerebral Small-Vessel Disease in Acute Intracerebral Hemorrhage.Prognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage: The INTERACT2 Study.Mannitol and Outcome in Intracerebral Hemorrhage: Propensity Score and Multivariable Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 2 Results.Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study.Significance of intraventricular hemorrhage in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial results.Clinical prediction algorithm (BRAIN) to determine risk of hematoma growth in acute intracerebral hemorrhage.Subarachnoid extension of intracerebral hemorrhage and 90-day outcomes in INTERACT2.Methods to improve patient recruitment and retention in stroke trials.Associations with health-related quality of life after intracerebral haemorrhage: pooled analysis of INTERACT studies.Withdrawal of active treatment after intracerebral haemorrhage in the INTERACT2 study.Predictive value of clinical lacunar syndromes for lacunar infarcts on magnetic resonance brain imaging.Increasing value and reducing waste in stroke research.Differences and similarities between spontaneous dissections of the internal carotid artery and the vertebral artery.Prophylactic heparin in acute intracerebral hemorrhage: a propensity score-matched analysis of the INTERACT2 study.Olive oil consumption, plasma oleic acid, and stroke incidence: the Three-City Study.Epileptic seizures at initial presentation in patients with brain arteriovenous malformation.
P50
Q24650299-22034AD1-5407-4124-B129-A3E304143027Q30299918-5AB4BE44-CCCB-4BBD-94CA-EE52CE715E45Q31031466-09D84526-8537-464B-819D-81637B13E8C3Q33400667-0985D0DB-478C-4817-8569-C59DA11BA921Q33913705-30C79C7C-832D-4988-8221-C3F70F5D04CDQ33993905-85BC9914-8900-49DA-B1A9-1F5AC37AA742Q34079303-8DBC25CD-FFE2-4267-9713-D436DD28C188Q34081311-31A0CD53-C628-439E-8ED7-CB37CB4AC9D9Q34511600-F23342C4-3454-47AE-935B-75C1632CEAEFQ34523086-D1DAE00E-0AB8-4E13-A4C3-6B8A95A6A1BDQ34578830-1EE5F4F6-EC15-4932-AEAB-972182FC72EBQ34591187-967B66FE-A9A0-44A7-B404-F8A285E6F361Q34994155-9C2F62D8-9A46-4251-80E9-C5712D6A045BQ35106446-FD804E8C-C2FD-4054-AAA3-BC82E246903EQ35468975-1C947F60-C5E2-40EA-BE5C-8F4F2340E1E7Q35918201-83FD84FD-F988-42A1-B2E1-2ADCCAE0D7C4Q36142857-6A99B722-E195-4299-A431-D5469ABE2420Q36369751-76BFDF12-4526-4FE8-9F15-DE2EBA63827AQ37017398-D0320BCE-2DDA-43E3-9BAA-660A34280783Q37293611-BE0BC135-FC60-40DE-B395-C708C4ACAD6DQ37745068-98BA2E98-CD89-4285-8216-8041C730BABAQ38270063-0AA77C3C-F02B-47A8-A6BE-15B51CC675A1Q38392967-692778A1-CE93-471E-9568-E68C88FD8B98Q38393696-1D7AC108-F62D-4714-B655-C0BB82DB9B2DQ38396272-5D95DB9A-A57E-41FA-AAA2-89D9CCA9CFF8Q38396678-36D4F3ED-E6EA-47BC-82FE-A0629BFA2234Q38406054-856200F7-8D01-42AB-A09D-53856CB8E62AQ38414438-2326B4B1-83AD-47B2-9ED8-213C6C7586C0Q38416325-FF9D1931-F945-481B-9CFB-45178A2BDD0EQ38419206-4C1DDB04-BABD-46BD-8E48-A3BB92E95B60Q38442535-B03D4F86-B2CD-40B2-9540-C68D24804B7DQ38818772-63985285-07FD-456E-B9BF-C5A624AB4AC8Q39129807-FCAD5211-1C54-42CA-86CA-1C737E49096CQ39199489-64AE4AB9-ECA5-4D09-B813-1A66790A46A7Q39224945-F0710219-4FB2-41EC-BA9A-562C23A9A71BQ39246077-FA99B915-7C89-4347-8198-12FBCA5EBE2AQ39427309-3706E6B7-21B5-42A5-BA67-559728726E3BQ39892632-7F49F00F-C189-46BC-8444-C4FA5AB99A78Q39987212-1DC60767-D282-4A90-A79D-0B7704BCFF1AQ40022096-C5E795DE-834E-489B-B256-055FA7E03776
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Christian Stapf
@ast
Christian Stapf
@en
Christian Stapf
@es
Christian Stapf
@nl
Christian Stapf
@sl
type
label
Christian Stapf
@ast
Christian Stapf
@en
Christian Stapf
@es
Christian Stapf
@nl
Christian Stapf
@sl
prefLabel
Christian Stapf
@ast
Christian Stapf
@en
Christian Stapf
@es
Christian Stapf
@nl
Christian Stapf
@sl
P214
P106
P1153
7003453445
P21
P214
P31
P496
0000-0002-3193-1006
P735
P7859
viaf-32785270